Capital Impact Advisors, LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 206 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
Capital Impact Advisors, LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$402,318
+4.3%
12,6000.0%0.44%
-6.3%
Q1 2023$385,812
-18.8%
12,600
+3.7%
0.47%
+1.7%
Q4 2022$475,382
-14.2%
12,155
+3.9%
0.46%
-15.8%
Q3 2022$554,000
+60.1%
11,697
+31.0%
0.55%
+72.5%
Q2 2022$346,000
-16.2%
8,931
+24.1%
0.32%
+6.7%
Q1 2022$413,000
-30.6%
7,199
-3.7%
0.30%
-26.8%
Q4 2021$595,000
-70.8%
7,472
-70.1%
0.41%
-18.2%
Q4 2020$2,041,00025,0000.50%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$304,095,00029.88%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,391$28,881,00022.15%
HSG Holding Ltd 796,089$102,465,0007.14%
DC Investments Management, LLC 21,010$2,704,0006.36%
PATHWAY CAPITAL MANAGEMENT, LP 112,197$14,441,0005.74%
Redmile Group, LLC 2,052,506$264,178,0003.91%
Casdin Capital, LLC 818,820$105,390,0002.68%
Darwin Global Management, Ltd. 126,985$16,344,0002.64%
Evolutionary Tree Capital Management, LLC 44,032$5,667,0002.61%
HHLR ADVISORS, LTD. 1,845,753$237,567,0002.44%
View complete list of BEAM THERAPEUTICS INC shareholders